A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

WASHINGTON -- An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting early hepatocellular carcinoma (HCC), according to a ...

Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...

ALTUS study is the largest prospective trial of a blood test for liver cancer surveillance in the United States, reflecting the racial and ethnic diversity of high-risk groups Exact Sciences Corp.

Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly. Most people with liver disease are symptom-free until complications like ...

Patients who are not eligible for surgical resection may or may not be eligible for liver transplant, depending on the extent of their disease, as outlined by the Milan and other criteria above. Some ...

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could nearly double by 2050. By Nina Agrawal Liver cancer kills more than 700,000 ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...